LAZ vs TCBI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
LAZ exhibits a stable but mediocre Piotroski F-Score of 4/9, while trading at a massive premium to its Graham Number ($21.31) and Intrinsic Value ($15.19). Despite strong ROE and consistent earnings beats, the company is facing a severe YoY earnings collapse of -43.30% and an unsustainable dividend payout ratio of 92.17%. Bearish insider activity and a 0/100 technical trend further signal a lack of confidence in the current price level of $48.51.
TCBI presents a stark contrast between strong valuation and weak fundamental health, highlighted by a critical Piotroski F-Score of 2/9. While the stock trades below its Graham Number ($112.18) and significantly below its growth-based intrinsic value ($219.19), the low health score suggests deteriorating operational efficiency or liquidity. Strong YoY earnings growth of 69.6% and recent earnings beats provide a bullish growth narrative, but these are offset by a bearish technical trend and fundamental instability. The overall outlook is neutral until the underlying health metrics improve.
Compare Another Pair
Related Comparisons
LAZ vs TCBI: Head-to-Head Comparison
This page compares Lazard, Inc. (LAZ) and Texas Capital Bancshares, Inc. (TCBI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.